Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure
Maria M. Beliaeva, Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, Sergey P. Golitsyn · 2023
Read Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure by Maria M. Beliaeva, Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, Sergey P. Golitsyn (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10744291.txt.
Description
Maria Beliaeva and eight co-authors wrote this 2023 study on a drug that resets a faulty heartbeat in patients with heart failure. The drug, cavutilide, is given by vein in up to four rising doses to convert atrial fibrillation back to a normal rhythm. The team reviewed patients with and without heart failure to see whether the weak heart changed the drug's power or safety.
It did not. After the full dose course, normal rhythm returned in about ninety-three percent of patients with heart failure and ninety percent without. Most conversions came within about twenty-three minutes. Serious slowing of the heart never appeared, though the heart's recovery interval stretched in some patients, and one brief dangerous rhythm was treated with magnesium. The authors judge the drug equally effective in both groups.
Catalog record
| CREATOR | Maria M. Beliaeva, Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, Sergey P. Golitsyn |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |